Conference Begins in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Day 2, November 21, 2025 - ET (Eastern Time, GMT-05:00)
- Chrissy Bradshaw - Senior Director, Brand and Compliance Counsel, Rocket Pharmaceuticals
This session defines strategies for demonstrating the effectiveness of your patient support program, focusing on return on impact, building your business case, balancing outcomes with costs and adapting to industry trends.
Identify crucial metrics, both qualitative and quantitative, for program success and implement best practices for consolidating fragmented data across various touchpoints
Develop strategies to secure leadership buy-in, justify budget allocations and effectively communicate the value of patient services to internal stakeholders. Determine the optimal level of support that balances patient needs with program sustainability.
Maintain a patient-first approach while managing financial constraints and consider the impact of policy and reimbursement changes on future support strategies
Participants will gain a valuable perspective on how to approach the evolving landscape where you must balance investments on the most impactful support services and models.
- Bob Sexton - Senior Vice President, Patient Services, Syneos Health Deployment Solutions
- Betsy Thorne - Senior Director, Market Access & Patient Support, Syneos Health Deployment Solutions
Analyze the strategic benefits of incorporating patient ambassadors into your PSP, the potential risks associated and best practices for implementation
Examine the unique compliance challenges posed by patient influencers and explore strategies for monitoring and managing user-generated content
Explore how to be innovative with patient engagement with a compliance-driven approach
- Kari Loeser - Vice President, Chief Compliance Officer, Cytokinetics
- Kelley Medeiros - Compliance Officer, Neuromodulation, LivaNova Plc.
The alignment of access, legal/compliance and patient services is essential in creating programs that are productive, meaningful and patient centric. Benchmark with colleagues on the best practices that can be instated in each of the respective departments in order to create and foster a relationship that is collaborative, mutualistic and working toward the common goal of helping the patient.
- Chrissy Bradshaw - Senior Director, Brand and Compliance Counsel, Rocket Pharmaceuticals
- Rakan Ghubej - Senior Director, Senior Corporate Counsel, Kyowa Kirin, Inc.
- Chris Dowd - Senior Vice President, ConnectiveRx
Every extra day a patient waits for therapy is a day their condition can worsen. During this session, explore how AI agents can revolutionize the patient access journey.
Discover practical AI implementations that streamline enrollment, benefits verification and prior authorization processes
Learn how to deploy AI solutions that reduce paperwork burden for healthcare providers
Explore real-world case studies showing dramatic reductions in time-to-therapy metrics
Understand how to integrate AI agents across multiple touchpoints including affordability programs, appointment scheduling and transportation coordination
Examine the measurable impact of these technologies on patient outcomes and satisfaction
- Kshitij Gupta - Co-Founder and CEO, 100ms
- Naresh Aggarwal - Head of Healthcare Solutions, 100ms
Picture this scenario…You’ve just successfully launched a complex product in a competitive space. But before you can even catch your breath, leadership is already starting to pepper you with questions about the long-term outlook for the program.
Sound familiar? If so, you’re not alone. As patient expectations evolve and technology rapidly advances, having a forward-thinking, organizational strategy isn’t just beneficial—it’s essential. Staying ahead means proactively shaping a long-term vision that keeps your program aligned with patient needs and reassures leadership—because we know they’ll be asking!
In this interactive session, we will tackle the following key questions leadership is sure to ask you.
What’s your 3-5 year strategy to be responsive, scalable, and competitive in the ever-evolving patient experience landscape?
What’s your plan for integrating AI and digital solutions to enhance the patient experience and streamline workflows?
How will your organizational design drive growth and innovation while staying agile in an ever-changing market?
What does it take to build a best-in-class program, and how do you assess how your patient support offering compares to other programs?
- Ed Gajewski - Principal, Nuvera Life Science Consulting
- Corey Ford - Principal, Nuvera Life Science Consulting
- Jens Kulstad - Head of PURE Engagement, Nuvera Life Science Consulting
AI in patient support shouldn't just replicate the way things have always been done – it should help patient support leaders reimagine what's possible. In this session, engage in a discussion with patient support leaders to offer a strategic lens for deploying AI not only to automate low-risk, high-volume tasks, but to fundamentally transform the patient experience. Attendees will learn how to assess where AI can reduce friction without compromising compliance, quality, or the human touch, as well as opportunities to shift from incremental improvements to meaningful change. The talk will include real-world examples and lessons learned from leading manufacturers, showcasing how strategic use of AI can streamline operations, improve time to therapy, and free up staff for higher-value work.
- Josh Feazell - Strategic Partnerships, Infinitus
- Michele Angelaccio - Vice President, Service Design & Platform Innovation, Novartis Patient Support, Novartis
As we approach the one-year mark of the new administration, this session examines the evolving healthcare landscape and its impact on patient support programs. Industry experts will explore how shifting priorities and regulatory changes are reshaping the patient services ecosystem, offering insights to adapt to this dynamic environment.
Analyze key healthcare policies and initiatives affecting patient services, including drug pricing reforms and accessibility measures
Discuss the implications of policy changes on digital health integration and patient support strategies
Explore innovative models for patient assistance that align with emerging healthcare priorities
Develop agile approaches to future-proof patient support programs in a rapidly changing landscape
Examine the potential impact of proposed tariffs on pharmaceutical imports, including their effects on drug prices, supply chain resilience and efforts to reshore manufacturing to the U.S.
- Chris Dowd - Senior Vice President, ConnectiveRx
- Mallory O’Connor - Executive Director, Public Policy, Mallinckrodt Pharmaceuticals
- Kristin Manzolillo - Senior Director and Team Lead, US Oncology Patient Solutions Strategy, Pfizer
Uncover the rapidly evolving landscape of direct-to-patient distribution channels in the pharmaceutical and healthcare industries.
Examine the driving forces behind the growth of direct-to-patient distribution models
Analyze successful case studies of pharmaceutical manufacturers implementing direct-to-patient channels
Explore the role of technology in enabling efficient and secure direct-to-patient distribution
Evaluate the impact of direct-to-patient distribution on patient outcomes, adherence and satisfaction
Identify strategies for overcoming logistical challenges and explore the integration of direct-to-patient channels with existing patient support programs and healthcare systems
In this closed-door summit, brainstorm with industry peers on the newest practices to mitigate risk from accumulators, maximizers and alternative funding programs and discuss the latest strategies to investigate and terminate suspicious pharmacy copay claims.
**Attendee qualification and approval for this session is at the discretion of Informa Connect. Please email callie.mertel@informa.com to sign up.
- Simon Kasmir - Director, Product Management, ConnectiveRx
- Kristine McGaughey - Vice President, Implementation, ConnectiveRx Jennie Sakimura, Senior Director, Patient Services & Specialty Pharmacy Programs, Sanofi
- Jennie Sakimura - Head, Patient Support Services, US General Medicines, Sanofi
- Ellis Wheby - Director, Patient Services & Distribution, Tarsus Pharmaceuticals
Join industry leaders for an insightful panel discussion exploring the nuances of patient support programs across large, mid-size and small pharmaceutical companies. This session will delve into the unique challenges, opportunities and best practices for each company size, providing valuable benchmarking insights for attendees.
Explore in-house vs. outsourced models for different company scales
Examine technology adoption and digital solutions across different company sizes
Discussing strategies for maintaining a patient-centric approach regardless of scale and explore innovative engagement techniques for companies with limited resources
Examine how patient support programs evolve as companies grow
- Loan Villaverde - Senior Director, Data Strategy, Claritas Rx
- Kate Friday - Vice President, Head of Patient Services, Teva Pharmaceuticals
- Lee Liberator - Vice President, Patient Services and Reimbursement, Priovant Therapeutics, Inc.
This session explores the rapidly evolving landscape of accumulators, maximizers and alternative funding programs, examining their impact on patient affordability and manufacturer strategies. Attendees will gain insights into emerging tactics and learn how to navigate the complex regulatory environment.
Analyze the future trajectory of accumulator and maximizer programs in light of potential regulatory changes
Explore emerging cost-shifting strategies employed by payers and PBMs
Examine the growing patchwork of state laws affecting copay programs
Discuss risk mitigation strategies to ensure long-term sustainability of patient support initiatives
- Anna Hyde - Vice President of Advocacy and Access, Arthritis Foundation
Explore the transformative potential of digital therapeutics (DTx) in enhancing patient support programs and improving health outcomes. This cutting-edge session delves into the integration of evidence-based digital interventions within the patient care journey, offering insights into the latest trends, best practices and future directions of DTx in patient support.st
Understand the fundamentals of digital therapeutics and their role in modern patient support strategies
Explore the regulatory landscape and approval processes for digital therapeutics
Discuss strategies for seamless integration of DTx into existing patient support programs
Analyze the impact of digital therapeutics on patient engagement, adherence and outcomes
Forecast future trends and innovations in the digital therapeutics space